Next Article in Journal
Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study
Next Article in Special Issue
Selection of Filovirus Isolates for Vaccine Development Programs
Previous Article in Journal
COVID-19 Pandemic Development in Jordan—Short-Term and Long-Term Forecasting
Previous Article in Special Issue
Better Pandemic Influenza Preparedness through Adjuvant Technology Transfer: Challenges and Lessons Learned
 
 
Article

Article Versions Notes

Vaccines 2021, 9(7), 731; https://doi.org/10.3390/vaccines9070731
Action Date Notes Link
article xml file uploaded 2 July 2021 15:36 CEST Original file -
article xml uploaded. 2 July 2021 15:36 CEST Update -
article pdf uploaded. 2 July 2021 15:36 CEST Version of Record https://www.mdpi.com/2076-393X/9/7/731/pdf-vor
article supplementary file uploaded. 2 July 2021 15:36 CEST - https://www.mdpi.com/2076-393X/9/7/731#supplementary
article html file updated 2 July 2021 15:37 CEST Original file -
article xml file uploaded 15 July 2021 11:45 CEST Update -
article xml uploaded. 15 July 2021 11:45 CEST Update https://www.mdpi.com/2076-393X/9/7/731/xml
article pdf uploaded. 15 July 2021 11:46 CEST Updated version of record https://www.mdpi.com/2076-393X/9/7/731/pdf
article html file updated 15 July 2021 11:47 CEST Update -
article html file updated 27 July 2022 03:15 CEST Update https://www.mdpi.com/2076-393X/9/7/731/html
Back to TopTop